DANA MARIE SMITH

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family GOLD CANYON, AZ NPI 1306228218

General Payments — all program years on this page

$726.82

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 39
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $392.19 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $392.1920

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2021 $234.5013
2022 $45.063
2023 $55.073
2024 $392.1920

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1087652673 Digestive Care, Inc. $15.85 02/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100284186 Novo Nordisk Inc $14.17 09/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100326698 Novo Nordisk Inc $21.48 12/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100435381 Novo Nordisk Inc $16.48 03/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100550992 Novo Nordisk Inc $14.02 04/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105457494 AstraZeneca Pharmaceuticals LP $14.67 09/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105820627 AstraZeneca Pharmaceuticals LP $13.19 04/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108216108 ABBVIE INC. $24.43 10/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114905667 Exact Sciences Corporation $25.35 01/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114905674 Exact Sciences Corporation $28.56 09/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114905685 Exact Sciences Corporation $24.99 11/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116378266 GlaxoSmithKline, LLC. $16.02 03/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117955484 Boehringer Ingelheim Pharmaceuticals, Inc. $16.23 04/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117955486 Boehringer Ingelheim Pharmaceuticals, Inc. $21.07 06/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137825574 Takeda Pharmaceuticals U.S.A., Inc. $23.53 08/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139481422 Astellas Pharma US Inc $14.90 02/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139519215 Astellas Pharma US Inc $23.59 05/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141675987 Merck Sharp & Dohme LLC $19.58 05/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153281888 Ultragenyx Pharmaceutical Inc. $26.03 04/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153356170 Dexcom, Inc. $18.05 09/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.